Nodal Marginal Zone Lymphoma
Nodal Marginal Zone Lymphoma (NMZL) is an indolent B-cell lymphoma that is found mostly in the lymph nodes. The disease is rare and only accounts for 1% of all Non-Hodgkin’s Lymphomas (NHL). It is most commonly diagnosed in older patients, with women more susceptible than men.
The disease is classified as a marginal zone lymphoma because the mutation occurs in the marginal zone of the B-cells. Due to its confinement in the lymph nodes, this disease is also classified as nodal.
Diagnosis and Staging
Symtoms include:
- Painless swelling of the lymph nodes
- Fever
- Night sweats
- Fatigue
- Weight loss
Diagnosis is made using a lymph node biopsy. Other tests, such as X-rays, CT scan, PET scan, ultrasound, and bone marrow biopsy are used to stage the disease. Staging is as follows:
- Stage I
- Only one group of lymph nodes is involved,
- Stage II
- Two groups of lymph nodes are involved, but they are on the same side of the diaphragm.
- Stage III
- Lymph nodes on both sides of the diaphragm are involved. The spleen is considered a lymph node in this staging system, so its involvement marks stage III.
- Stage IV
- The bone marrow, liver, or other organs are involved.
Most patients are diagnosed in the earlier stages of disease.
Treatment
As this is a very slow growing disease, the "Watch and Wait" method may be employed for patients who don’t have many symptoms. Other treatment include:
- Chemotherapy
- NMZL is very reactive to chemotherapy. Administration of the drugs chlorambucil and/or fludarabine usually results in remission of the disease.
- Radiation
- Radiotherapy is given alone in the early stages of disease, or in combination with chemotherapy for late stages of the disease.
- Radiolabeled Isotopes
- Radioimmunotherapy treatments such as the Zevalin regimen are being researched as a treatment for marginal zone lymphomas and shows promising results.
- Clinical Trials
- Patients who are looking for more advanced treatment or who have lymphoma that does not respond to standard treatment may want to consider a clinical study. Click here to find clinical trials in your area.
Related Articles
More Articles
More Articles
According to a study by Japanese researchers, the SMILE combination chemotherapy protocol is effective against extranodal natural killer/T-cell...
Patients treated with maintenance rituximab had three times longer progression-free survival. This is a summary of an article published in the...
When you consider that the adult human body has anywhere from 300 to 700 lymph nodes, the better question might not be where ARE they located, but...
This entry looks at a non-Hodgkin's lymphoma called true histiocytic lymphoma (THL), also referred to as diffuse histiocytic lymphoma, and...
Lymphomatous meningitis [LM], also known as leukemic meningitis, is an extremely serious peripheral cancer that attacks the tissue that covers the...
Hodgkin's Disease—also referred to as Hodgkin's Lymphoma, these are the exact same diseases, just...
Intravascular lymphoma is a subtype of 'Lymphoma', an umbrella term that loosely refers to several dozen...
While the average lifespan for hamsters is only about 2.5 years, and they are therefore less prone to long-term illnesses, it is possible for a...
Burkitt's lymphoma is an aggressive B-cell lymphoma that is common in children...
Lymphoma is a cancer of the lymphatic system, causing B-cell or...
The term NK T cell lymphoma refers to one of two subtypes of lymphoma that affect the NK (Natural Killer)...
Lymphoma is a life-threatening disease, but is very treatable in most cases. The 5-year survival for patients diagnosed with non-Hodgkin's...
T cell lymphoma treatment options for these cancers are not especially effective and there is no absolute consensus about optimal treatments for...
Lymphomas can arise from most any lymphatic tissue (lymph nodes, spleen, thymus, mucosa associated lymphoid...
